A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the WW SEC filings page.
This page shows WW International, Inc. (WW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
WW’s operating model weakened through FY2024, while FY2025’s balance-sheet reset sharply reduced financing pressure and restored positive equity.
Cash conversion deteriorated in FY2024: the company paired a net loss of$345.7M with operating cash flow of-$16.8M , indicating that reported earnings were not translating into cash generation. FY2025 then reports net income of$1.06B but no revenue or operating cash flow, so that reversal cannot yet be read as recurring operating recovery.
FY2024’s revenue fell
FY2025 reports positive equity of
Financial Health Signals
We do not publish a peer-relative financial health score for WW International, Inc., because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
WW International, Inc. passes 5 of 5 computable financial strength tests (4 of the nine could not be computed from available data). All 2 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass.
Key Financial Metrics
Earnings & Revenue
WW International, Inc. generated $152.9M in revenue in Q3 2026. This represents a decrease of 11.2% from the same quarter a year earlier. Against the prior quarter it is down 5.8%.
WW International, Inc.'s EBITDA was $49.6M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 40.8% from the same quarter a year earlier. Against the prior quarter it is up 40.0%.
WW International, Inc. reported $15.1M in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 7.3%.
WW International, Inc. earned $1.51 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 7.1%.
Cash & Balance Sheet
WW International, Inc. held $126.4M in cash against $424.0M in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
WW International, Inc.'s gross margin was 71.1% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.8 percentage points.
WW International, Inc.'s operating margin was 23.9% in Q3 2026, reflecting core business profitability. This is up 19.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 18.0 percentage points.
WW International, Inc.'s net profit margin was 9.9% in Q3 2026, showing the share of revenue converted to profit. This is up 43.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.2 percentage points.
WW International, Inc.'s quarterly ROE was 5.1% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 23.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.
Capital Allocation
None of these metrics is reported for Q3 2026.
WW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $152.9M-11.2% | $162.3M-8.3% | $168.3M-9.8% | N/A | $172.1M-10.8% | $177.0M-12.4% | $186.6M-9.7% | $184.4M-10.5% |
| Cost of Revenue | $44.2M-7.9% | $48.2M+3.6% | $49.6M-7.6% | N/A | $48.0M-24.3% | $46.5M-28.2% | $53.7M-21.9% | $55.9M |
| Gross Profit | $108.7M-12.4% | $114.1M-12.5% | $118.7M-10.7% | N/A | $124.1M-4.2% | $130.5M-4.9% | $132.9M-3.6% | $128.5M+2.9% |
| SG&A Expenses | $33.8M-43.7% | $50.4M+17.5% | $48.1M+35.0% | N/A | $60.1M+5.4% | $42.9M+16.0% | $35.6M-39.6% | $35.2M |
| Operating Income | $36.5M+354.4% | $9.5M-77.1% | -$30.4Mn/m | N/A | $8.0Mn/m | $41.4M+15.2% | -$20.2Mn/m | $36.2Mn/m |
| EBITDA | $49.6M+40.8% | $35.4M-27.3% | -$4.6Mn/m | N/A | $35.2Mn/m | $48.7M+7.1% | -$13.3Mn/m | $44.9M+467.5% |
| Interest Expense | $11.4M-5.4% | $12.0M+8.9% | $12.2M-56.9% | N/A | $12.1M-57.9% | $11.1M-61.3% | $28.2M+14.1% | $28.7M |
| Income Tax | $10.7M-79.9% | -$11.2Mn/m | $10.8M-52.1% | N/A | $53.2Mn/m | -$20.9Mn/m | $22.6M-59.3% | -$11.7M-120.4% |
| Net Income | $15.1Mn/m | $14.1M-98.8% | -$52.0Mn/m | N/A | -$57.5Mn/m | $1.2B+5017.1% | -$72.6Mn/m | $25.1Mn/m |
| EPS (Basic) | $1.51n/m | $1.41 | -$5.20 | N/A | -$5.76 | $14.81 | -$0.91n/m | $0.33n/m |
| EPS (Diluted) | $1.51n/m | $1.41 | -$5.20 | N/A | -$5.76 | $14.67 | -$0.91n/m | $0.33n/m |
| Diluted Shares (Avg) | 10M+0.3% | 10M | 10M | N/A | 10M | 81M | 80M+1.2% | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
WW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $847.3M-12.5% | $840.4M-18.6% | $881.1M+26.4% | $946.8M+72.1% | $968.8M+72.3% | $1.0B+68.2% | $696.9M+6.5% | $550.3M-44.0% |
| Current Assets | $161.5M-26.4% | $146.9M-44.2% | $168.3M-40.1% | $213.6M+108.1% | $219.3M+116.7% | $263.2M+198.8% | $281.3M+140.4% | $102.6M-42.8% |
| Cash & Equivalents | $126.4M-25.7% | $101.5M-33.4% | $120.9M-48.9% | $160.3M+202.3% | $170.1M+197.6% | $152.4M+256.8% | $236.3M+254.8% | $53.0M-51.5% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $199.9M-0.1% | $199.9M+0.4% | $200.0M-16.8% | $200.1M-16.5% | $200.1M-17.6% | $199.1M-17.7% | $240.3M-0.8% | $239.6M-1.6% |
| Total Liabilities | $554.1M-14.2% | $561.8M-13.9% | $615.5M-67.3% | $628.7M-62.2% | $645.8M-61.8% | $652.1M-61.7% | $1.9B+6.4% | $1.7B-4.5% |
| Current Liabilities | $92.1M-30.7% | $106.1M-24.3% | $141.1M-92.3% | $126.5M-27.0% | $133.0M-29.8% | $140.1M-30.1% | $1.8B+631.4% | $173.3M-15.6% |
| Non-Current Liabilities | $462.0M-9.9% | $455.7M-11.0% | $474.4M+715.2% | $502.2M-66.3% | $512.8M-65.8% | $512.1M-65.9% | $58.2M-96.2% | $1.5B-3.0% |
| Long-Term Debt | $424.0M-8.9% | $424.0M-8.9% | $438.6M | $465.5M-67.5% | $465.5M-67.4% | $465.5M-67.4% | N/A | $1.4B+0.3% |
| Total Equity | $293.3M-9.2% | $278.6M-26.9% | $265.6Mn/m | $318.1Mn/m | $323.0Mn/m | $381.0Mn/m | -$1.2Bn/m | -$1.1Bn/m |
| Retained Earnings | -$84.9Mn/m | -$100.0M-8076.2% | -$114.1M-106.2% | -$62.1M-103.2% | -$56.3M-102.9% | $1.3M-99.9% | $1.9B-5.7% | $1.9B-16.4% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable.
WW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $32.3M+283.9% | $24.3Mn/m | -$33.5M-323.7% | -$2.9M-162.8% | $8.4M-49.1% | -$49.4Mn/m | $15.0Mn/m | $4.6M-41.2% |
| Depreciation & Amortization | $13.0M-52.0% | $25.9M+255.6% | $25.9M+274.4% | $26.3M+203.1% | $27.2M+196.8% | $7.3M-23.7% | $6.9M-33.5% | $8.7M-37.6% |
| Stock-Based Compensation | N/A | N/A | $391K-54.5% | N/A | N/A | N/A | $860K-64.2% | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | $6K | $82K-67.7% | $5K-98.9% | $120K-64.9% |
| Free Cash Flow | N/A | N/A | N/A | N/A | $8.4M | -$49.5Mn/m | $15.0Mn/m | $4.5M-40.1% |
| Investing Cash Flow | -$7.0Mn/m | -$6.1Mn/m | -$5.8Mn/m | -$8.5Mn/m | -$4.7Mn/m | -$3.2Mn/m | -$3.2Mn/m | -$3.2Mn/m |
| Financing Cash Flow | $0 | N/A | N/A | N/A | N/A | -$17.4Mn/m | $171.2Mn/m | -$208Kn/m |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
WW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.1%-1.0pp | 70.3%-3.4pp | 70.5%-0.7pp | N/A | 72.1%+5.0pp | 73.7%+5.8pp | 71.2%+4.5pp | 69.7%+9.1pp |
| Operating Margin | 23.9%+19.2pp | 5.8%-17.5pp | -18.1%-7.3pp | N/A | 4.7%+24.9pp | 23.4%+5.6pp | -10.8% | 19.6%+22.6pp |
| Net Margin | 9.9%+43.3pp | 8.7% | -30.9%+8.0pp | N/A | -33.4%-9.5pp | 672.7% | -38.9% | 13.6%+56.4pp |
| Return on Equity | 5.1%+23.0pp | 5.1%-307.5pp | -19.6% | N/A | -17.8% | 312.5% | N/A | N/A |
| Return on Assets | 1.8%+7.7pp | 1.7%-113.6pp | -5.9%+4.5pp | N/A | -5.9%+2.3pp | 115.3%+111.5pp | -10.4%+42.8pp | 4.6%+13.5pp |
| Current Ratio | 1.75+0.1x | 1.38-0.5x | 1.19+1.0x | 1.69+1.1x | 1.65+1.1x | 1.88+1.4x | 0.15-0.3x | 0.59-0.3x |
| Debt-to-Equity | 1.450.0x | 1.52+0.3x | 1.65 | 1.46 | 1.44 | 1.22 | N/A | N/A |
| Liabilities-to-Equity | 1.89-0.1x | 2.02+0.3x | 2.32 | 1.98 | 2.00 | 1.71 | N/A | N/A |
| Asset Turnover | 0.180.0x | 0.190.0x | 0.19-0.1x | N/A | 0.18-0.2x | 0.17-0.2x | 0.270.0x | 0.34+0.1x |
| FCF Margin | N/A | N/A | N/A | N/A | 4.9% | -28.0%-26.9pp | 8.0%+25.7pp | 2.4%-1.2pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| WW International, Inc. WW | FY2025 | N/A | $1.1B | N/A | $79.7M | — |
| The Joint Corp. JYNT | FY2025 | $54.9M | $2.9M | 5.3% | $88.0M | 26/100 |
| AirSculpt Technologies, Inc. AIRS | FY2025 | $151.8M | -$11.7M | -7.7% | $48.4M | 47/100 |
| Cryo-Cell International Inc. CCEL | FY2025 | $31.6M | -$2.4M | -7.7% | $33.5M | 27/100 |
| Auna S.A. AUNA | FY2025 | $1.3B | $29.0M | 2.2% | $288.8M | 53/100 |
| Community Health Systems, Inc. CYH | FY2025 | $12.5B | $509.0M | 4.1% | $227.1M | 40/100 |
Where WW International, Inc. Ranks
Frequently Asked Questions
Yes, WW International, Inc. (WW) reported a net income of $1.1B in fiscal year 2025.
As of fiscal year 2025, WW International, Inc. (WW) had $160.3M in cash and equivalents against $465.5M in long-term debt.
WW International, Inc. (WW) has a return on equity of 332.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
WW International, Inc. (WW) had $946.8M in total assets as of fiscal year 2025, including both current and long-term assets.
WW International, Inc. (WW) had a current ratio of 1.69 as of fiscal year 2025, which is generally considered healthy.
WW International, Inc. (WW) had a debt-to-equity ratio of 1.46 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
WW International, Inc. (WW) had a liabilities-to-equity ratio of 1.98 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
WW International, Inc. (WW) had a return on assets of 111.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
WW International, Inc. (WW) trades at 0.1x earnings, its market capitalization divided by $1.1B net income, FY2025. The market capitalization is $79.7M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
WW International, Inc. (WW) has no price-to-sales ratio at the moment: no full year of revenue reported yet. The market capitalization is $79.7M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
WW International, Inc. (WW) has a Piotroski F-Score of 5 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.